Hjem › Multipelt myelom › Arkansas
Kliniske studier for Multipelt myelom i Arkansas
9 studier for Multipelt myelom søker deltakere på steder i Arkansas.
Byer i Arkansas
Offisiell studietekst (engelsk)
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
- Highlands Oncology Group, Springdale
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07518186A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
- UAMS, Little Rock
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07258511A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
- University of Arkansas for Medical Sciences, Little Rock
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT04634552A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma
- Highlands Oncology Group, PA, Springdale
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 24. sep. 2026 · NCT07477587Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
- University of Arkansas for Medical Sciences, Little Rock
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT06297226Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
- Mercy Hospital Fort Smith, Fort Smith
- CARTI Cancer Center, Little Rock
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 19. aug. 2026 · NCT04566328A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
- Highlands Oncology Group - Springdale /ID# 267742, Springdale
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 13. jul. 2026 · NCT05650632Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
- Mercy Hospital Fort Smith, Fort Smith
- CARTI Cancer Center, Little Rock
- University of Arkansas for Medical Sciences, Little Rock
RekruttererFase 3
Alle aldre · Alle kjønn · Oppdatert 10. jun. 2026 · NCT05561387Limited-duration Teclistamab
- University of Arkansas for Medical Sciences, Little Rock
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2025 · NCT05932680Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.